Macular degeneration trials in New Zealand

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A First-In-Human Study of ARO-033 in Adult Participants

  Where

  Auckland

  Age

  18 years to 65 years

  People

  84

  Run by

  Arrowhead Pharmaceuticals

  See details and how to joinNCT07662096
• No phaseTaking people
  Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  Where

  Remuera

  Age

  60 years and over

  People

  100 worldwide

  Run by

  i-Lumen Scientific AUS PTY LTD

  See details and how to joinNCT06662162
• Phase 1/2Taking people
  A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

  Where

  Christchurch

  Age

  55 years to 80 years

  People

  62 worldwide

  Run by

  Kriya Therapeutics, Inc.

  See details and how to joinNCT06765980